Retatrutide is a new pharmaceutical in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By stimulating these receptors, https://caoimhetujn096152.blogzag.com/79657505/tirzepatide-a-promising-new-treatment-for-obesity